John Lewis, PhD

FOUNDER, CHIEF EXECUTIVE OFFICER

John Lewis is the Bird Dogs Chair in Translational Oncology at the University of Alberta in Edmonton, Alberta. As a scientist and serial entrepreneur, he pioneered the use of intravital imaging in the in vivo study of tumour cell invasion and metastasis to discover key targets for cancer therapeutics. Dr. Lewis also develops novel nanotechnology, nanoparticle drug delivery technologies, and imaging-based treatments for chronic diseases, such as aging and cancer, as well as for early detection of cancers. Dr. Lewis trained at The Scripps Research Institute and received a Ph.D. in biochemistry from the University of Victoria.